Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- SANDPIPERIndependent statistical analysis of A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase…
- SANICSIIIndependent statistical analysis of SANICS II Trial: Stimulation of the Autonomic Nervous System in Colorectal Surgery by Perioperative Nutrition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly: Complete Statistical AnalysisIndependent statistical analysis of Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03312231).
- Sanofi H1N1 + TIV – Adults and Elderly: Complete Statistical AnalysisIndependent statistical analysis of Sanofi H1N1 + TIV - Adults and Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00943878).
- Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations: Complete Statistical AnalysisIndependent statistical analysis of Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- SAPHEIndependent statistical analysis of Somatuline Autogel Preference and Health Economy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00681187).
- Saphenous Nerve Block for Foot and Ankle Surgery: Complete Statistical AnalysisIndependent statistical analysis of Saphenous Nerve Block for Foot and Ankle Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02382744).
- Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SAPPHIREIndependent statistical analysis of Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SAPPHIREIndependent statistical analysis of Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03001414).
- SAPPHIRE PhAIndependent statistical analysis of SEARCH SAPPHIRE Phase A: A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SARA-INTIndependent statistical analysis of A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03452488).
- Saracatinib and Alcohol Drinking: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib and Alcohol Drinking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955186).
- Saracatinib in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01267266).
- Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors: Complete Statistical AnalysisIndependent statistical analysis of SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SARCAIndependent statistical analysis of Lansoprazole to Treat Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442013).
- Sarizotan in Participants With Parkinson’s Disease Suffering From Treatment Associated Dyskinesia: Complete Statistical AnalysisIndependent statistical analysis of Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SARONAPLUSIndependent statistical analysis of Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SARS-CoV-2 Human Challenge Characterisation Study: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2 Human Challenge Characterisation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04865237).
- SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631705).
- SASHIndependent statistical analysis of Poor Sleep and Inflammation in HIV-Infected Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03848325).
- SASHIndependent statistical analysis of Social Work Assistance and Stipends for Housing (SASH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05803603).
- SAT1Independent statistical analysis of University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SAT2HIV-IIIndependent statistical analysis of The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04687917).
- SATISFACTIONIndependent statistical analysis of Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SATisfaction and Adherence to COPD Treatment: Complete Statistical AnalysisIndependent statistical analysis of SATisfaction and Adherence to COPD Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02689492).
- Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Satisfaction of Treatment Among Elderly Patients With Insulin Therapy: Complete Statistical AnalysisIndependent statistical analysis of Satisfaction of Treatment Among Elderly Patients With Insulin Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240200).
- Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence: Complete Statistical AnalysisIndependent statistical analysis of Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747850).
- SatraGO-2Independent statistical analysis of A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SaVEIndependent statistical analysis of Utilizing Text Messaging to Improve Vehicle Safety Among At-Risk Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Saved From COVID-19 – Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID: Complete Statistical AnalysisIndependent statistical analysis of Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Savella in Treatment for Provoked Vestibulodynia: Complete Statistical AnalysisIndependent statistical analysis of Savella in Treatment for Provoked Vestibulodynia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01304589).
- SAVINOIndependent statistical analysis of Saypha® Volume LIdocaine in Nasolabial Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04883632).
- Savolitinib vs. Sunitinib in MET-driven PRCC.: Complete Statistical AnalysisIndependent statistical analysis of Savolitinib vs. Sunitinib in MET-driven PRCC.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03091192).
- SAWHIIndependent statistical analysis of Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SAXAPCOSIndependent statistical analysis of Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SayLipIndependent statistical analysis of Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SayWhenIndependent statistical analysis of Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SBIndependent statistical analysis of An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SBATIndependent statistical analysis of School-based Asthma Therapy: Stage 2 Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01175369).
- SBIRT-PTSDIndependent statistical analysis of Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SBRTvsTACEIndependent statistical analysis of Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study: Complete Statistical AnalysisIndependent statistical analysis of SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: Complete Statistical AnalysisIndependent statistical analysis of SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALPIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp: primary endpoint results, effect…
- SCANIndependent statistical analysis of Evaluation of Imaging of Peripheral Arteries by Optical Coherence Tomography and Intravascular Ultrasound Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…